Authors

  • Shukurova F.N., Eshmurzayeva A.A., Narmatova K.Sh.

Keywords:

surunkali diffuziv jigar kasalliklari, revmatoid artrit, mikroRNK-122, mikroRNK-221.

References

1. Gareyev I.F., Beylerli O.A. Циркулирующие микроРНК как биомаркеры: какие перспективы? Профилактическая медицина, 6, 2018

2. Karimov, M.Sh., Shukurova, F.N., Parpiboyeva, D.A. (2020). Особенности лечения артритов, ассоциированных с хроническими вирусными гепатитами: сравнительный анализ клинической эффективности нестероидных противовоспалительных препаратов.

3. Shukurova, F.N., Karimov,M.Sh. (2022). Поражение суставов, ассоциированное с хроническим гепатитом C: современные методы диагностики (Монография).

4. Abo El Atta A.S., Ali Y.B.M., Bassyouni I.H., Talaat R.M. Upregulation of miR-221/222 expression in rheumatoid arthritis (RA) patients: correlation with disease activity. Clin Exp Med 2019;19:47–53.

5. Blank M., Gershwin M.E. (2008) Autoimmunity: from the mosaic to the kaleidoscope. J.Autoimmun 30:1–4

6. Castro R.E., et al. Mir-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J. Hepatol. 2013;58:119–25

7. Csak T., et al. MicroRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 2015; 35: 532–41.

8. Chentoufi A.A., Serov Y.A., Alazmi M., Baba K. (2014) Immune components of liver damage associated with connective tissue diseases. J.Clin.Transl.Hepatol.2(1):37–44

9. Das S., Padhan P. (2017) An overview of the extraarticular involvement in rheumatoid arthritis and its management. J.Pharmacol. Pharmacother 8(3):81–86

10. Durham, A.L. Basic science: Epigenetic programming and the respiratory system/AL. Durham, IM. Adcock//Breathe. – 2013. – №9. – P. 278-288.

11. Filková M., Jüngel A., Gay R.E., et al. MicroRNAs in rheumatoid arthritis. BioDrugs. 2012;26(3):131–141.

12. Hisano C. [et al.] // A case of hemophagocytic syndrome manifesting adult Still's disease and acute hepatitis / Nihon Rinsho Meneki Gakkai Kaishi. - 1995. - Vol. 18, № 2. - P. 256-264

13. Lee J.E., Kim I.J., Cho M.S., Lee J. (2017) A case of rheumatoid vasculitis involving hepatic artery in early rheumatoid arthritis. J. Korean Med.Sci. 32(7):1207–1210

14. Liaskos C., Bogdanos D.P., Rigopoulou E.I., Dalekos G.N. (2007) Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J.Gastroenterol Hepatol.22(3):454–455

15. Miao C., Yang Y., He X. и др. Новые достижения микроРНК в патогенезе ревматоидного артрита с акцентом на взаимодействие между метилированием ДНК и механизмом микроРНК. Сотовый сигнал. 2013; 25 (5): 1118–1125.

16. O’Rourke J.M., Sagar V.M., Shah T., Shetty S. Carcinogenesis on the background of liver fibrosis: implications for the management of hepatocellular cancer. WorldJ. Gastroenterol. 2018. V. 24 (39). P. 4436-4447

17. Pandis I., Ospelt C., Karagianni N. et al.Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis 2012;71:1716–23.

18. Parpibaeva D. A., Shukurova F. N., Shakirovich K. M. Non-invasive biomarkers of liver fibrosis: universality and availability //Journal of critical reviews. – 2020. – Т. 7. – №. 17. – С. 2251-2257.

19. Poupon R. (2010) Primary biliary cirrhosis: a 2010 update. J.Hepatol. 52:745–758

20. Rigby W.F.C, Lampl K., Low J.M., Furst D.E. (2017) Review of routine laboratory monitoring for patients with rheumatoid arthritis receiving biologic or nonbiologic DMARDs. Int J.Rheumatol 2017:9614241